This implies that ROS may play a tumor-promoting role in cisplatin-treated HGC-27 cells, and overexpression of OPN-a may enhance the anti-tumor effect of cisplatin in HGC-27 cells by inhibiting the generation of ROS. Here, SPP1 is linked to neoplasm.